TELA | TFX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 86 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 36 | 58 | |
P/E GROWTH RATING 1..100 | 100 | 1 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TELA's Valuation (39) in the null industry is somewhat better than the same rating for TFX (91) in the Medical Specialties industry. This means that TELA’s stock grew somewhat faster than TFX’s over the last 12 months.
TELA's Profit vs Risk Rating (100) in the null industry is in the same range as TFX (100) in the Medical Specialties industry. This means that TELA’s stock grew similarly to TFX’s over the last 12 months.
TFX's SMR Rating (97) in the Medical Specialties industry is in the same range as TELA (100) in the null industry. This means that TFX’s stock grew similarly to TELA’s over the last 12 months.
TELA's Price Growth Rating (36) in the null industry is in the same range as TFX (58) in the Medical Specialties industry. This means that TELA’s stock grew similarly to TFX’s over the last 12 months.
TFX's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for TELA (100) in the null industry. This means that TFX’s stock grew significantly faster than TELA’s over the last 12 months.
| TELA | TFX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 63% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 89% | 1 day ago 54% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 72% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 70% |
| Advances ODDS (%) | 18 days ago 76% | 12 days ago 58% |
| Declines ODDS (%) | 1 day ago 85% | 1 day ago 71% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 58% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 64% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TELA’s FA Score shows that 0 FA rating(s) are green while TFX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TELA’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 6 bullish TA indicator(s).
TELA (@Medical/Nursing Services) experienced а -16.00% price change this week, while TFX (@Pharmaceuticals: Other) price change was -1.52% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.67%. For the same industry, the average monthly price growth was -6.60%, and the average quarterly price growth was -6.64%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.77%. For the same industry, the average monthly price growth was -3.89%, and the average quarterly price growth was +12.09%.
TELA is expected to report earnings on Nov 11, 2026.
TFX is expected to report earnings on Oct 22, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.77% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNGD | 23.47 | 0.74 | +3.26% |
| MicroSectors FANG+ Index - 3X Inverse Leveraged ETN (FNGD) | |||
| MSFD | 9.79 | 0.13 | +1.36% |
| Direxion Daily MSFT Bear 1X ETF (MSFD) | |||
| POWA | 88.18 | 1.08 | +1.24% |
| Invesco Bloomberg Pricing Power ETF (POWA) | |||
| EMLC | 24.78 | 0.01 | +0.04% |
| VanEck J. P. Morgan EM Local Currency Bond ETF (EMLC) | |||
| GVIP | 171.50 | -2.11 | -1.22% |
| Goldman Sachs Hedge Industry VIP ETF (GVIP) | |||
A.I.dvisor tells us that TELA and BAX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and BAX's prices will move in lockstep.
| Ticker / NAME | Correlation To TELA | 1D Price Change % | ||
|---|---|---|---|---|
| TELA | 100% | -1.87% | ||
| BAX - TELA | 28% Poorly correlated | -0.29% | ||
| AMIX - TELA | 27% Poorly correlated | -8.21% | ||
| HBIO - TELA | 27% Poorly correlated | -4.35% | ||
| TFX - TELA | 27% Poorly correlated | -0.23% | ||
| AZTA - TELA | 26% Poorly correlated | +0.31% | ||
More | ||||